logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-21. Gender ratio by primary drug - ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2005 for countries supplying data [see all tables in this series...]

Part (ii) Gender ratio (ratio of males to females) among all clients entering outpatient treatment

CountryOpioidsCocaineStimulantsHypnotics and sedativesHallucinogensVolatile substancesCannabisOther drugsBase (known status)
Bulgaria(1)4.40.52.50.73.6850
Czech Republic2.21.51.80.91.53.83.50.52047
Denmark(2)3.43.52.81.61.03.62.84043
Germany3.35.32.30.72.71.95.74.355595
Ireland(3)2.43.93.62.00.95.50.53685
Greece5.54.12.03.21.50.35.43.02235
Spain(4)4.96.23.91.38.27.66.21.651253
France3.63.52.61.77.32.75.92.716872
Italy(5)5.410.04.31.210.51.548304
Cyprus(6)5.23.91.01.07.8258
Lithuania4.34.52.31.89.012.711.55.65371
Luxembourg(7)2.52.10.71.51.6272
Hungary2.92.73.10.52.68.57.81.39534
Malta(8)7.05.04.05.1496
Netherlands5.05.63.11.16.04.04.60.79411
Slovakia(9)2.72.90.47.56.71.0954
Finland(10)2.31.01.52.12.81.21645
Sweden1.54.61.40.91.01.03.54.11739
United Kingdom2.62.91.91.32.01.53.32.499076
Total 3.24.72.11.03.82.85.32.43.7
Total base16753451218135726635646845674005790313640

Notes:

 (1) No female cases for other drugs; no cases for Volatile substances and hallucinogens. 

 (2) No female cases for hallucinogens. 

 (3) No female cases for hallucinogens. 

 (4) Data refer to 2004. 

 (5) No female cases for hallucinogens and volatile substances. 

 (6) No female cases for stimulants; no cases for Volatile substances and other drugs. 

 (7) No female cases for other drugs; no cases for Volatile substances and hallucinogens. 

 (8) No female cases for hypnotics and volatile substances; no cases for hallucinogens and other drugs. 

 (9) No female cases for hallucinogens and cocaine. 

 (10) No female cases for hallucinogens and volatile substances. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - TDI - outpatient treatment centres. 

Page last updated: Monday, 12 November 2007